239 related articles for article (PubMed ID: 27706243)
1. Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index (ALI) in Patients with Small Cell Lung Cancer_ Comparison with Original ALI.
Kim EY; Kim N; Kim YS; Seo JY; Park I; Ahn HK; Jeong YM; Kim JH
PLoS One; 2016; 11(10):e0164056. PubMed ID: 27706243
[TBL] [Abstract][Full Text] [Related]
2. Exploring the implications of modified advanced lung cancer inflammation index on outcomes in patients with advanced non-small cell lung cancer.
Mahajan A; Goyal D; Agarwal U; Patil V; Shukla S; Noronha V; Joshi A; Menon N; Prabhash K
Explor Target Antitumor Ther; 2023; 4(5):896-911. PubMed ID: 37970209
[TBL] [Abstract][Full Text] [Related]
3. Advanced Lung Cancer Inflammation Index, a New Prognostic Score, Predicts Outcome in Patients With Small-Cell Lung Cancer.
He X; Zhou T; Yang Y; Hong S; Zhan J; Hu Z; Fang W; Qin T; Ma Y; Zhao Y; Cheng Z; Huang Y; Zhao H; Yang G; Zhang L
Clin Lung Cancer; 2015 Nov; 16(6):e165-71. PubMed ID: 25922292
[TBL] [Abstract][Full Text] [Related]
4. Prognostic Significance of Modified Advanced Lung Cancer Inflammation Index in Patients With Renal Cell Carcinoma Undergoing Laparoscopic Nephrectomy: A Multi-Institutional, Propensity Score Matching Cohort Study.
Mao W; Wang K; Wu Y; Ni J; Zhang H; Wang Y; Wu Z; Liu R; Geng J; Chen S; Chen M
Front Nutr; 2021; 8():781647. PubMed ID: 35127784
[TBL] [Abstract][Full Text] [Related]
5. Prognostic Significance of CT-Determined Sarcopenia in Patients with Small-Cell Lung Cancer.
Kim EY; Kim YS; Park I; Ahn HK; Cho EK; Jeong YM
J Thorac Oncol; 2015 Dec; 10(12):1795-9. PubMed ID: 26484630
[TBL] [Abstract][Full Text] [Related]
6. Does advanced lung inflammation index (ALI) have prognostic significance in metastatic non-small cell lung cancer?
Ozyurek BA; Ozdemirel TS; Ozden SB; Erdoğan Y; Ozmen O; Kaplan B; Kaplan T
Clin Respir J; 2018 Jun; 12(6):2013-2019. PubMed ID: 29356383
[TBL] [Abstract][Full Text] [Related]
7. Impact of pretherapeutic neutrophil-to-lymphocyte ratio, serum albumin, body-mass index, and advanced lung cancer inflammation index on clinical outcome in sinonasal squamous cell carcinoma.
Brkic FF; Kadletz L; Jank B; Mayer C; Heiduschka G; Brunner M
J Craniomaxillofac Surg; 2020 Jan; 48(1):33-37. PubMed ID: 31810849
[TBL] [Abstract][Full Text] [Related]
8. The advanced lung cancer inflammation index is an independent prognostic factor after surgical resection in patients with non-small-cell lung cancer.
Tomita M; Ayabe T; Nakamura K
Interact Cardiovasc Thorac Surg; 2018 Feb; 26(2):288-292. PubMed ID: 29049691
[TBL] [Abstract][Full Text] [Related]
9. Sarcopenia defined by skeletal muscle mass index at the third lumbar vertebra is a prognostic factor for extensive-stage small cell lung cancer patients: a retrospective study.
Wang K; Long W; Sima X; Zhao Y; Xiao B; Gulizeba H; Huang Y
J Thorac Dis; 2022 Jul; 14(7):2645-2651. PubMed ID: 35928624
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of sarcopenia in small-cell lung cancer patients by routine chest CT.
Kim EY; Kim YS; Park I; Ahn HK; Cho EK; Jeong YM; Kim JH
Support Care Cancer; 2016 Nov; 24(11):4721-6. PubMed ID: 27364150
[TBL] [Abstract][Full Text] [Related]
11. The prognostic significance of the advanced lung cancer inflammation index in patients with unresectable metastatic colorectal cancer: a retrospective study.
Shibutani M; Maeda K; Nagahara H; Fukuoka T; Matsutani S; Kimura K; Amano R; Hirakawa K; Ohira M
BMC Cancer; 2019 Mar; 19(1):241. PubMed ID: 30885163
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of the combination of body composition and systemic inflammation in patients with cancer cachexia.
Xie HL; Ruan GT; Wei L; Zhang Q; Ge YZ; Song MM; Zhang X; Lin SQ; Liu XY; Zhang XW; Li XR; Zhang KP; Hu CL; Yang M; Tang M; Song CH; Cong MH; Weng M; Li ZN; Li W; Wang KH; Shi HP
J Cachexia Sarcopenia Muscle; 2023 Apr; 14(2):879-890. PubMed ID: 36872512
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of cachexia score assessed by CT in male patients with small cell lung cancer.
Kim EY; Lee HY; Kim YS; Park I; Ahn HK; Cho EK; Jeong YM; Kim JH
Eur J Cancer Care (Engl); 2018 Jan; 27(1):. PubMed ID: 28426181
[TBL] [Abstract][Full Text] [Related]
14. Extra-thoracic tumor burden but not thoracic tumor burden on (18)F-FDG PET/CT is an independent prognostic biomarker for extensive-disease small cell lung cancer.
Oh JR; Seo JH; Hong CM; Jeong SY; Lee SW; Lee J; Min JJ; Song HC; Bom HS; Kim YC; Ahn BC
Lung Cancer; 2013 Aug; 81(2):218-25. PubMed ID: 23731740
[TBL] [Abstract][Full Text] [Related]
15. The Relationship between Sarcopenia and Systemic Inflammatory Response for Cancer Cachexia in Small Cell Lung Cancer.
Kim EY; Kim YS; Seo JY; Park I; Ahn HK; Jeong YM; Kim JH; Kim N
PLoS One; 2016; 11(8):e0161125. PubMed ID: 27537502
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of metabolic parameters measured by (18)F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer.
Zhu D; Ma T; Niu Z; Zheng J; Han A; Zhao S; Yu J
Lung Cancer; 2011 Sep; 73(3):332-7. PubMed ID: 21292341
[TBL] [Abstract][Full Text] [Related]
17. A Low Advanced Lung Cancer Inflammation Index Predicts a Poor Prognosis in Patients With Metastatic Non-Small Cell Lung Cancer.
Lu P; Ma Y; Kai J; Wang J; Yin Z; Xu H; Li X; Liang X; Wei S; Liang X
Front Mol Biosci; 2021; 8():784667. PubMed ID: 35096967
[No Abstract] [Full Text] [Related]
18. Prognostic value of the modified advanced lung cancer inflammation index in overweight or obese patients with lung cancer: Results from a multicenter study.
Xie H; Ruan G; Wei L; Zhang Q; Ge Y; Song M; Zhang X; Lin S; Liu X; Li X; Zhang K; Yang M; Tang M; Song C; Shi H
JPEN J Parenter Enteral Nutr; 2023 Jan; 47(1):120-129. PubMed ID: 35975336
[TBL] [Abstract][Full Text] [Related]
19. Advance lung cancer inflammation index (ALI) at diagnosis is a prognostic marker in patients with metastatic non-small cell lung cancer (NSCLC): a retrospective review.
Jafri SH; Shi R; Mills G
BMC Cancer; 2013 Mar; 13():158. PubMed ID: 23530866
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of metabolic tumor burden from (18)F-FDG PET in surgical patients with non-small-cell lung cancer.
Zhang H; Wroblewski K; Liao S; Kampalath R; Penney BC; Zhang Y; Pu Y
Acad Radiol; 2013 Jan; 20(1):32-40. PubMed ID: 22999369
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
